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Percutaneous stentingAim: To evaluate the effectiveness and safety of percutaneous transhepatic stent place-
ment in management of hepatic venous outflow obstruction after living-donor liver trans-
plantation (LDLT).
Materials and methods: From September 2010 to May 2015 percutaneous transhepatic
venography was performed in 30 patients of 489 patients who underwent LDLT with sus-
pected hepatic venous outflow obstruction with stent placement performed in 25 patients.
Patient follow-up included clinical and laboratory data collection, Doppler ultrasonography
(US), hepatic venography, and computed tomography. Technical success, complications,
clinical improvement, and recurrence were evaluated.
Results: Technical success was achieved in all patients. The mean pressure gradients across
the stenosis before and after the procedure were 17.8 mmHg ± 6.4 (range, 3–39 mmHg)
and 2.4 mmHg ± 2.6 (range, 0–8 mmHg), respectively. Four patients developed recurrent
stenosis, and these patients underwent balloon angioplasty and remained with no events
until the end of the observation period. During the mean follow-up period of 21 months
(range 10–40 months) clinical success was achieved in 24 of 25 patients (96%).
Conclusion: In conclusion, percutaneous transhepatic stenting is safe and effective for
venous outflow obstruction after LDLT.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by
Elsevier. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/4.0/).1. Introduction good management option for hepatic venous outflowHepatic venous outflow obstruction is considered to be
one of the observed complications of living donor liver
transplantation (LDLT) with a relative rare occurrence of
2–4% [1–3]. The patency of venous outflow is critical to graft
survival. Obstruction of the venous outflow causes graft
congestion which leads to massive ascites and ultimately
graft failure [4,5]. Balloon venoplasty alone seems to be aobstruction [6–9], yet it is not considered to be an effective
treatment for various etiologies of venous outflow abnor-
malities with high re-stenosis rate [10].
In this article, we describe the efficacy, safety and
patency of percutaneous transhepatic venous stenting for
post LDLT hepatic outflow obstruction.2. Patients and methods
2.1. Patients
Between September 2010 and May 2015, 30 patients
(27 males and 3 females; median age 51 years) of total
Fig. 1. Male patient 59 years old, presented with abnormal liver functions 9 months post LDLT. (A) Duplex examination showed monophasic flow in the
hepatic vein. (B) Multislice CT confirmed the venous stenosis, the patient underwent venography with pressure gradient 10 mmHg before and stent was
placed and dropped to 2 mmHg post-stenting with normalization of liver enzymes after.
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obstruction were subjected to transhepatic percutaneous
venography. These patients underwent living donor living
transplantation between May 2010 and January 2015.
11 patients (36%) with left lobe grafts and 19 with right
lobe grafts were suspected having outflow obstruction due
to the presence of intractable ascites, pleural effusion or
lower limb edema with abnormal monophasic venous flow
patterns at Doppler ultrasonography or unexplained
abnormal liver functions.
Hepatic outflow obstruction was diagnosed mainly by
Doppler ultrasonography, and multi-slice CT was per-
formed in equivocal cases or for confirmation. Findings to
suggest venous outflow obstruction on Doppler were
dilated hepatic vein >6 mm at the periphery of the graft,
disappearance of triphasic waveform pattern of hepatic
veins and/or flat monophasic flow seen in the hepatic vein
(Fig. 1).
Common abnormal laboratory data were mainly ele-
vated liver enzymes, high bilirubin and low albumin levels.
All the procedures were done under general anesthesia;
an informed consent was taken after explaining the proce-
dure details and possible interventions and risks. In all 30
patients venography was performed via the transhepatic
percutaneous approach. The age of the patients ranged
from 29 to 57 years (median age 51 years), with the time
between transplantation and the venography procedure
was 2–10 months (median 4 months).
Venous outflow obstruction was confirmed by venogra-
phy in 25 patients of the total 30, and significant hepatic
vein stenosis was defined with a dilated hepatic vein
observed to more than 30% stenosis at the junction with
IVC with stasis dye at the anastomosis, with or without
the presence of collaterals and/or a more than 5 mmHg
pressure gradient across the anastomosis.
2.2. Procedure
Under US guidance, after a small skin snip, the targeted
hepatic vein was punctured (11 patients left hepatic vein,
19 patients right hepatic vein). A 16-gauge needle was
used for a transhepatic puncture of the vein (rather than
transvenous route). The inner stylet of the needle waswithdrawn and a successful puncture was confirmed by
contrast media injection, a 0.032-in. angled hydrophilic
guide wire (Radifocus; Terumo, Tokyo, Japan) was
advanced into the hepatic vein, over the guide wire a 7-F
interventional sheath introducer was inserted, followed
by a control subtracted venogram of the hepatic vein and
IVC in direct posteroanterior and oblique projections.
Stenotic segment was identified in 25 patients which
was bypassed using the guide wire and a 4 or 5-F catheter
with cobra head configuration (Tepo; Cordis, Johnson and
Johnson, USA) was inserted across the anastomosis. From
this catheter, pressure gradient across the anastomosis
(between hepatic vein and IVC or right atrium) was
recorded using an invasive monitor. Patients with a pres-
sure gradient of more than 5 mmHg were diagnosed to
have significant venous outflow obstruction that requires
stent placement.
In all 25 cases a 10 mm bare self-expandable metallic
stent (Wallstent, Boston scientific, USA) was placed across
the anastomosis, following stent placement, a subtracted
post stenting hepatic venography was done with post
stenting measurement of pressure gradient across the
anastomosis. Further post stenting dilatation with balloons
was preformed when radiological or manometric results
were unsatisfactory.
After completion of the procedure the introducer sheath
was then removed, the puncture site was not coli embo-
lized and post procedural Doppler US was done to confirm
stent patency and detect any bleeding (Fig. 2).2.3. Follow-up evaluation
Doppler US was done every week in the first month, and
then every month. Clinical evaluation, liver functions and
laboratory tests were performed for all patients every
month as well.
Recurrence of symptoms of hepatic outflow obstruc-
tion, with or without abnormal laboratory data or Doppler
US findings suggesting stent malfunction was an indication
for a hepatic venography; balloon venoplasty using a
10 mm balloon with stent reopening was performed when
restenosis or stent occlusion was found.
Fig. 2. A 46 year old male 6 months post LDLT for Budd Chiari Syndrome presented with ascites and abnormal liver functions. (A) Subtracted venogram
showing high grade stenosis at junction of Right HV and IVC with multiple collaterals seen. (B) After passage of guide wire with pressure gradient 15 mmHg.
(C) After stent deployment and finally. (D) Control venogram, note disappearance of collaterals with drop of pressure down to 2 mmHg.
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complications, recurrence and outcome of venoplasty,
and patency rates were evaluated.3. Results
3.1. Technical success
Of the 30 patients who underwent venography and
manometric measurements, we found 25 patients with
pressure gradient more than 5 mmHg between the hepatic
vein and IVC with positive venography findings, and 5
patients had a pressure gradient of 3 mmHg or less without
venography findings suggesting outflow obstruction. And
in the 25 patients with high pressure gradient percuta-
neous transhepatic stent placement was successfully per-
formed; technical success was 100% in these patients.3.2. Manometric findings
The mean pressure gradient (venous pressure in the IVC
subtracted from that in the liver graft before the anastomo-
sis) was 17.8 mmHg ± 6.4 (ranging from 5 to 39 mmHg)
before stenting and 2.4 mmHg (ranging from 0 to 8 mmHg)
after stenting. A major difference was found pre and poststenting with statistically significant drop in pressure
(P < 0.01).
3.3. Clinical success
Clinical success was obtained in 24 out of 25 patients
(96%) with resolution of the ascites and normalization of
liver enzymes with triphasic waveform pattern of the hep-
atic vein. One patient showed no clinical improvement
however with significant improvement of the hepatic flow
but with persistent elevated liver enzymes and ascites and
was diagnosed as graft rejection (liver biopsy) and sent for
re-transplantation.
3.4. Complications
No major complications were encountered during the
course of the study, and no cases of serious post procedural
bleeding were recorded. As to minor complication, tran-
sient fever and pain were observed in two patients, which
were managed conservatively.
3.5. Recurrence
Recurrence of outflow obstruction after the stent place-
ment was observed in 5 patients; follow-up in these
Fig. 3. Kaplan–Meier curve showing patency rates post stent placement.
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tion was mostly recurrent accumulation of ascites, 4
patients had recurrent outflow obstruction and one patient
suffered from graft rejection with normal flow on Doppler
examination. All four patients underwent hepatic venogra-
phy with balloon venoplasty and reopening of the stent
while the fifth patient was sent for re-transplantation.3.6. Patency rate
The primary patency rate throughout the follow-up per-
iod was 80% with confidence intervals (CIs) calculated at 6,
12, 14, 16 and 20 months after stenting (Fig. 3) 0.96, 0.92,
0.72, 0.52, and 0.48, respectively. The primary assisted and
secondary patency rates were 1.00 throughout the follow-
up period (Fig. 3).4. Discussion
Post LDLT hepatic venous outflow obstruction is not
uncommon, and this is likely attributed to the presence
of accessory hepatic veins and the frequent need of more
than one hepatic venous anastomoses. Post LDLT hepatic
venous outflow occlusion was reported to be from 3.9%
to 16.6% [1,7].
Early (<30 days) post LDLT hepatic outflow obstruction
will lead to a congested graft and will induce deterioration
in liver functions, acute graft failure, or even death [1,11]
and this is considered as a surgical emergency, and surgical
correction is mostly the option of choice [12]. While
delayed hepatic venous outflow obstruction usually results
in gradual deterioration of liver function, with ascites and
surgical correction is usually un-preferred due to severe
perianastomotic fibrosis. Thus interventional radiological
procedures are superior to surgical correction in these
cases [13]. So, early and adequate management of post
transplant hepatic venous outflow obstruction is manda-
tory for graft survival.
Balloon venoplasty alone seems to be an effective and
safe for management of post transplant hepatic venous
outflow stenosis [6]; however, there is still a high inci-
dence of restenosis and recurrence of symptoms, and sev-
eral studies showed that there is high rate of restenosis
after venoplasty alone (up to 60%) most of which in thefirst 6 months, which needed further stent placement
[3,14].
A transhepatic approach for hepatic vein puncture was
applied in all our cases under real time sonographic guid-
ance. Access to the hepatic vein can be done via both per-
cutaneous transhepatic and transluminal approaches,
weather transjugular or transfemoral with nearly equal
results [3]. However, we believe that dealing with stenosis
via guide wires appears to be much easier with the percu-
taneous transhepatic route because passage through the
stenosis is likely straightforward with this route. This is
resulting in less procedure time, less contrast media and
decreased exposure of the patient to ionizing radiation.
Theoretically the transhepatic approach may be more
liable to serious bleeding. However, in our study, no signif-
icant bleeding was reported despite we did not embolize
the tract in hepatic parenchyma with coli or gel foam at
the end of the procedure because we succeeded to bypass
the stricture and relive the hepatic congestion in all our
cases.
Although stents may be susceptible to thrombosis and
sometimes could interfere with re-transplantation, our
rate of thrombosis was relatively low 4 over 25 (16%),
and on analysis we found three of these four patients were
diagnosed preoperatively as Budd Chiari disease and
thrombosis was mostly due to uncontrolled thrombophilia,
as recurrence of Budd Chiari Syndrome after transplanta-
tion has been reported to be as high as 27% and may
require re-transplantation [15].
There were no major surgical or technical limitations in
the patient who was sent for re-transplantation as the
position of the stent was not reaching the suprahepatic
part of inferior vena cava, so proper stent placement is
essential to not interfere with further surgical corrections,
and no cases of stent migration were reported in our study.
Regarding stent diameter, we used a standard stent
diameter (10 mm) in all our patients, as that was the mean
vein diameter in the pre procedural duplex US examina-
tion, and a study done by Ko et al. (2008) showed less
restenosis rate in large diameter stents (10 and 12 mm)
compared to smaller stents (6 and 8 mm) [16].
An interesting issue is the high number of left lobe
grafts in our study (36%) despite the low number of left
lobe grafts in the adult LDLT practice in our country,
several data reported increased rate of post LDLT hepatic
outflow obstruction in patients receiving left lobe grafts,
Fig. 4. 56 year old male with left lobe graft presented 18 months post-transplant with ascites, venography showed markedly dilated vein with faint IVC
filling (A), after passage of guide wire (B), after stent deployment note good filling of IVC and atrium (C), and on subtracted image (D), drop of gradient from
18 mmHg to 3 mmHg.
M. El-Gharib et al. / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1391–1396 1395compared with those having right lobe grafts (5.8% vs.
0.8%). This difference is likely due to increased anatomic
variation of the left hepatic vein and to the surgical and
technical challenges presented by the angle and size of
the reconstruction [17,18] (Fig. 4).
A main limitation in our study is the small number of
patients, which might not have been enough to evaluate
the complications of percutaneous transhepatic approach,
and more studies are needed to compare this approach
with the transluminal one. Also a comparative study
regarding long-term patency between stenting and balloon
venoplasty is also needed as the question of whether to
treat hepatic venous outflow obstruction in this patient
population with venoplasty alone or with metallic stent
placement still remains controversial.
5. Conclusion
Percutaneous transhepatic stenting is a safe and effec-
tive method for treating hepatic venous outflow obstruc-
tion after LDLT with good outcome.Conflict of interest
The authors declare that they have no conflict of
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